Protea Announces Research Agreement with Mass General Hospital
9 August 2017
Protea Biosciences Group, Inc. announced today that it had entered into a Collaboration Research Agreement with the Vaccine and Immunotherapy Center (VIC), Division of the Massachusetts General Hos